2009
DOI: 10.1086/599005
|View full text |Cite
|
Sign up to set email alerts
|

Cost-Effectiveness Analysis of a Silver-Coated Endotracheal Tube to Reduce the Incidence of Ventilator-Associated Pneumonia

Abstract: "Cost-effectiveness analysis of a silver-coated endotracheal tube to reduce the incidence of ventilator-associated pneumonia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
39
0
1

Year Published

2010
2010
2015
2015

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 63 publications
(41 citation statements)
references
References 33 publications
1
39
0
1
Order By: Relevance
“…28 This cost could be prohibitive to patients in low-income areas, where access to such a device would provide great therapeutic benefit. Finally, using an embedding technique rather than a coating technique is promising for greater retention of antibacterial effects over time.…”
Section: Discussionmentioning
confidence: 99%
“…28 This cost could be prohibitive to patients in low-income areas, where access to such a device would provide great therapeutic benefit. Finally, using an embedding technique rather than a coating technique is promising for greater retention of antibacterial effects over time.…”
Section: Discussionmentioning
confidence: 99%
“…A cost-effectiveness analysis of silver-coated ETTs in preventing VAP used the following assumptions in the model: tube placement in all nonelective intubations, VAP risk of 9.7% using uncoated ETTs, VAP relative risk reduction of 24% using silver-coated ETTs, marginal hospital costs of $16,620, and a cost of $90 for the silvercoated tube and $2 for the uncoated tube. 173 The cost savings per case of VAP prevented was determined to be $12,840. Using these same assumptions, a breakeven point was estimated to be $388, meaning that the cost of the coated tube would have to increase to $388 to offset the savings per case.…”
Section: Subglottic Secretion Drainagementioning
confidence: 99%
“…However, the recommendations included in the guidelines are not unequivocal in this respect [15]. It appears that using such tubes is warranted in patients in whom ventilatory support is expected to last longer than 48 hours, as such patients are at high risk of VAP occurrence [23].…”
Section: Intubation and Mechanical Ventilationmentioning
confidence: 99%